10-KPeriod: FY2023

EIDP, Inc. Annual Report, Year Ended Dec 31, 2023

Filed February 8, 2024For Securities:CTA-PBCTA-PA

Summary

EIDP, Inc. (Corteva Agriscience) operates as a global leader in the agriculture industry, providing essential seed and crop protection solutions. The company's business is structured into two primary segments: Seed and Crop Protection, serving farmers in approximately 125 countries. Corteva distinguishes itself through a robust innovation pipeline, a broad portfolio of products, and a direct engagement model with farmers. The company's strategy focuses on accelerating performance through portfolio simplification, royalty neutrality, product mix enhancement, and operational improvements, alongside increased investment in R&D for sustainable solutions. Key strategic priorities include disciplined capital deployment, balancing investments, growth, M&A opportunities, and returning cash to shareholders. The company recently strengthened its biologicals offerings through the acquisitions of Stoller Group Inc. and Symborg. Financially, Corteva reported net sales of $17.2 billion for the year ended December 31, 2023, a slight decrease from the prior year, impacted by lower volumes but offset by price increases and acquisitions. Operating EBITDA improved year-over-year, driven by pricing and productivity actions. The company returned approximately $1.2 billion to shareholders through share repurchases and dividends in 2023 and continues to prioritize returning capital to shareholders, evidenced by its ongoing share repurchase program and dividend increases. The company's outlook for 2024 remains constructive, with projected net sales between $17.4 billion and $17.7 billion and Operating EBITDA between $3.5 billion and $3.7 billion, signaling continued focus on growth and profitability.

Key Highlights

  • 1Corteva operates globally in two core segments: Seed and Crop Protection, aiming to enhance farmer productivity and sustainability.
  • 2The company made strategic acquisitions of Stoller Group Inc. and Symborg to bolster its biologicals portfolio, complementing its existing offerings.
  • 3Net sales for the year ended December 31, 2023, were $17.2 billion, reflecting a slight decrease primarily due to lower volumes, partially offset by price increases and acquisitions.
  • 4Operating EBITDA increased to $3.38 billion for the year ended December 31, 2023, driven by strong pricing execution and productivity initiatives.
  • 5Corteva returned approximately $1.2 billion to shareholders in 2023 through share repurchases and dividends, demonstrating a commitment to capital returns.
  • 6The company has a strong innovation pipeline and invests significantly in R&D to deliver differentiated and sustainable agricultural solutions.
  • 7The company forecasts net sales of $17.4 billion to $17.7 billion and Operating EBITDA of $3.5 billion to $3.7 billion for 2024.

Frequently Asked Questions

Corteva's business is organized into two primary reportable segments: Seed, which develops and supplies commercial seed with advanced germplasm and traits for high yield potential, and Crop Protection, which provides products to protect crop yields against weeds, insects, and diseases.

For the year ended December 31, 2023, Corteva reported net sales of $17.2 billion, a slight decrease of 1% compared to the prior year, driven by a 10% decrease in volume partially offset by a 7% price increase and a 3% favorable portfolio impact. Operating EBITDA improved to $3.38 billion, up from $3.22 billion in the prior year, due to price execution and productivity actions.

Corteva's key priorities include accelerating performance through value creation network catalysts like portfolio simplification and royalty neutrality, increasing investment in its innovation pipeline for differentiated and sustainable solutions, and deploying capital with discipline by balancing investments, growth, M&A opportunities, and returning cash to shareholders.

Yes, on March 1, 2023, Corteva completed the acquisitions of Stoller Group Inc., a major independent company in the Biologicals industry, and Symborg, an expert in microbiological technologies. These acquisitions are expected to enhance its crop protection business with additional biological tools.